Doug Sommerville ran a $ 1.3 BILLION TEVA EMPIRE Doug Sommerville (CEO and DIRECTOR)
Is a veteran leader in the North American medical, pharmaceutical and technology industries. Prior to joining Medivolve, Mr. Sommerville held the role of Head of Country for Canada for Teva Canada, a subsidiary of Teva Pharmaceutical Industries Ltd. (“Teva”), the world’s leading provider of generic medicines. In this role, Mr. Sommerville was responsible for Teva’s third largest global subsidiary, with sales in excess of $1.3 billion. Douglas led all aspects of the company’s commercial, distribution, demand planning and customer operations – aligning and coordinating all company functions, production, supply chain, regulatory and global support functions. Douglas was also the Chairman of the Canadian Generic Pharmaceutical Association up until his retirement from Teva Canada in 2018.
Previous to his tenure at Teva Canada, Mr. Sommerville was Global Vice President, Infusion Systems with Baxter Healthcare International (“Baxter”), one of the world’s largest medical, pharmaceutical and technology companies. In his role, Douglas was responsible for the company’s infusion pumping devices and intravenous administration sets worldwide, as well as pain management and ambulatory infusion devices, working with Baxter’s product development, regional sales and marketing teams globally.
Dr. Beverley J. Richardson (Director)
is a renowned psychotherapeutic practitioner whose collaborative efforts and clinical influence are reflected in some of the most compelling and effective addiction and behavioural health programs in North America which include: Sierra Tucson (Arizona), the Meadows (Arizona) and Betty Ford Centre (California).
She has a Doctorate Degree in Psychology and is a B.C. Registered Clinical Counsellor, Internationally Certified Eating Disorder Specialist, and EMDR Level II Trauma Therapist. Dr. Richardson has integrated her extensive experience in health and wellness with her entrepreneurial spirit to form her nutraceutical and bioscience research and development enterprises.
Daniyal Baizak (DIRECTOR)
is a seasoned professional with considerable experience providing financial and strategic advice on mergers, acquisitions and managing multiple projects for a variety of private and public companies. With experience in Central Asian and Russian markets, Daniyal plays a key role in navigating and finding new investment opportunities in frontier and emerging markets for F&M.
Wen Ye (DIRECTOR)
is a CPA, CGA and holds a Bachelor of Commerce degree from Laurentian University. Ms. Ye brings over 17 years of corporate and finance management experience in the public mining, securities and logistics sectors.
===============================================================
The criminals want you to believe that all of the above people decided to throw away their careers for some type of fraud of a few million $$$.
For Doug, this lack of trust is rather INSULTING when you know his track record.
MPO